Prevention of relapses in systemic lupus erythematosus (Q72318708)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783536%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

title

Prevention of relapses in systemic lupus erythematosus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783536%20AND%20SRC:MED&resulttype=core&format=json

systemic lupus erythematosus

25 October 2019

main subject

0 references

10

C Kallenberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783536%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

author name string

H Bootsma

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783536%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

P Spronk

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783536%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

R Derksen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783536%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

G de Boer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783536%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

H Wolters-Dicke

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783536%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

J Hermans

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783536%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

P Limburg

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783536%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

F Gmelig-Meyling

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783536%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

L Kater

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783536%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

publication date

1 June 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783536%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

language of work or name

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783536%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

volume

345

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783536%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

issue

8965

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783536%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

page(s)

1595-1599

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783536%20AND%20SRC:MED&resulttype=core&format=json

Outcome of systemic lupus erythematosus. A study of 66 patients over 7 years with special reference to the predictive value of anti-DNA antibody determinations

25 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990114-0

7 January 2021

The time-dependence of long-term prediction in lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990114-0

7 January 2021

Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990114-0

7 January 2021

Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990114-0

7 January 2021

Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990114-0

7 January 2021

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990114-0

7 January 2021

Immunosuppressive drug therapy in lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990114-0

7 January 2021

Immunologic factors and clinical activity in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990114-0

7 January 2021

Correlation between levels of DNA antibodies and clinical disease activity in SLE.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990114-0

7 January 2021

Reassessment of the clinical significance of native dna antibodies in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990114-0

7 January 2021

Anti‐dsdna and complement profiles as prognostic guides in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990114-0

7 January 2021

Immune Complexes, Complement, and Anti-DNA in Exacerbations of Systemic Lupus Erythematosus (SLE)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990114-0

7 January 2021

Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990114-0

7 January 2021

Changes in plasma levels of interleukin-2 receptor in relation to disease exacerbations and levels of anti-dsDNA and complement in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990114-0

7 January 2021

STEROID THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS BASED ON IMMUNOLOGIC CONSIDERATIONS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990114-0

7 January 2021

The effect of normalization of serum complement and anti-DNA antibody on the course of lupus nephritis: a two year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990114-0

7 January 2021

The effect of continuous normalization of serum hemolytic complement on the course of lupus nephritis: a five year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990114-0

7 January 2021

Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990114-0

7 January 2021

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990114-0

7 January 2021

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990114-0

7 January 2021

The first international standard for antibodies to double stranded DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990114-0

7 January 2021

Effect of long-term normalization of serum complement levels on the course of lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990114-0

7 January 2021

Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990114-0

7 January 2021

Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990114-0

7 January 2021

10.1016/S0140-6736(95)90114-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783536%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

1 reference